Back to search

Article

Flexible delivery of opioid agonist treatment during COVID-19 in Norway: A cross-sectional survey of provider experiences

2023-01-18

Abstract excerpt

<title>Abstract</title> <p><bold>Background and Aims:</bold> For patients receiving daily opioid agonist treatment (OAT) for opioid dependence, several countries relaxed treatment guidelines at the beginning of the COVID-19 pandemic. This involved longer take-home intervals for methadone and buprenorphine doses as well as a reduction in supervised dosing and drug screening. To date, little is known about the medi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7e52e270-acac-5d08-9609-0d39f0bddda7
DOI
10.21203/rs.3.rs-2212348/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Flexible delivery of opioid agonist treatment during COVID-19 in Norway: A cross-sectional survey of provider experiencesDOI 10.21203/rs.3.rs-2212348/v1
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023Semantic proximity
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023Semantic proximity
Changes in opioid prescribing during the COVID-19 pandemic in England: cohort study of 20 million patients in OpenSAFELY-TPPSemantic proximity
Development of quality indicators for the continued and safe delivery of Opioid Agonist Treatment (OAT), throughout and beyond COVID-19, using a Delphi Consensus techniqueSemantic proximity
Patient Perspectives on Buprenorphine Treatment for Opioid Use Disorder and Preferences for Long-Acting Injectable Formulations: Findings from a National Online SurveySemantic proximity
“The idea is to help people achieve greater success and liberty”: a qualitative study of expanded methadone take-home access in opioid use disorder treatmentSemantic proximity
Experiences of Opioid Use and Perceptions of Medication-Assisted Treatment (MAT) in Oakland's Safety Net Clinics Amid the COVID-19 PandemicSemantic proximity
Exploring Opioid Management Challenges in Chronic Non-Tumor Pain: Findings from a Mixed-Methods Study among General PractitionersSemantic proximity
The Impact of CARA Mandates on Nurse Practitioner Controlled Substance Prescribing in Oregon: A Cohort StudySemantic proximity
The effects of a provincial opioid prescribing standard on opioid prescribing for pain: interrupted series analysisSemantic proximity
General practice patients starting treatment for substance use problems: observations from two data sources across levels of careSemantic proximity
Opioid prescribing to people on orthopaedic waiting lists during the COVID-19 pandemic in England: a study using OpenSAFELY-TPPSemantic proximity
Select a neighboring publication to make it the new centre.